Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy

Details for Australian Patent Application No. 2002352843 (hide)

Owner Burzynski, S.

Inventors Burzynski, Stanislaw R.

Agent EF WELLINGTON & CO

Pub. Number AU-B-2002352843

PCT Number PCT/US02/37354

PCT Pub. Number WO2003/045372

Priority 09/995,010 27.11.01 US

Filing date 21 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 19 April 2007

International Classifications

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

A61K 31/185 (2006.01) - Acids

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 31/525 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 39/02 (2006.01) General protective or antinoxious agents

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 09/995,010 27.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002352843

19 April 2007 Application Accepted

  Published as AU-B-2002352843

16 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352844-THERMAL STIR WELDING PROCESS AND APPARATUS

2002352842-METHOD FOR SEMI-AUTOMATIC GENERATION AND BEHAVIORAL COMPARISON OF MODELS